Tenax Therapeutics (TENX) Finished Goods (2012 - 2014)
Tenax Therapeutics (TENX) reported Finished Goods of $68658.0 for Q1 2014, down 13.27% on a YoY basis from $79159.0 in Q1 2013, and down 0.79% sequentially from $69206.0 in Q4 2013.
Tenax Therapeutics (TENX) Finished Goods (2012 - 2014) Analysis & Trends
Tenax Therapeutics (TENX) has 3 years of Finished Goods data on file, last reported at $68658.0 in Q1 2014.
- For the quarter ending Q1 2014, Finished Goods fell 13.27% year-over-year to $68658.0; the trailing twelve-month figure through Jan 2014 stood at $68658.0 (down 13.27% YoY), and the FY2013 full-year result was $70425.0, up 21.86% from the prior year.
- Finished Goods retreated to $68658.0 in Q1 2014, from $69206.0 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $80578.0 in Q4 2012 to a low of $49480.0 in Q3 2012.
- A 3-year average of $68181.8 and a median of $69681.5 in 2013 frame the typical range for Finished Goods.
- Peak annual rise in Finished Goods reached 41.79% in 2013, while the deepest fall reached 14.11% in 2013.
- Tracing TENX's Finished Goods over 3 years: stood at $80578.0 in 2012, then retreated by 14.11% to $69206.0 in 2013, then declined by 0.79% to $68658.0 in 2014.
- Business Quant data shows TENX's Finished Goods at $68658.0 in Q1 2014, $69206.0 in Q4 2013, and $70157.0 in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2014 | 68,658.00 |
| Oct 31, 2013 | 69,206.00 |
| Jul 31, 2013 | 70,157.00 |
| Apr 30, 2013 | 70,425.00 |
| Jan 31, 2013 | 79,159.00 |
| Oct 31, 2012 | 80,578.00 |
| Jul 31, 2012 | 49,480.00 |
| Apr 30, 2012 | 57,791.00 |